Functional and physiological outcomes in axial spondyloarthritis: comparing biological and non-biological treatment approaches
- 25 September 2025
- journal article
- Published by Taylor & Francis in Physiotherapy Theory and Practice
- Vol. 42 (2) , 239-251
Abstract
Pharmacological treatments have been shown to improve physical and physiological functions in patients with axial spondyloarthritis (axSpA). This study aimed to compare core endurance, exercise capacity, cardiopulmonary responses during exercise testing, quality of life (QoL), and disease activity among patients with axSpA using biological and non-biological treatments, and healthy controls. This cross-sectional study involved 52 patients on biological therapy, 57 on non-biological drugs, and 46 healthy controls. Core endurance (McGill tests), exercise capacity (six-minute stepper test), and disease activity indexes (The Bath Ankylosing Spondylitis Disease Indices; BASDAI, BASMI, BASFI, ASDAS-CRP, Leeds Enthesitis Index; LEI), spinal and hip radiographic scores (modified Stoke Ankylosing Spondylitis Spinal Score; mSASSS), Bath Ankylosing Spondylitis Radiology Hip Index; BASRI-hip), pain (Numeric Rating Scale), patient and physician global assessments, cardiopulmonary responses, quadriceps muscle fatigue and dyspnea (Modified Borg scale), laboratory markers (CRP, ESR), and QoL (Ankylosing Spondylitis QoL Scale; ASQoL) were measured. Step counts in the six-minute stepper test, trunk flexor, and lateral flexor muscle endurance values were significantly lower, while fatigue and quadriceps muscle fatigue during the six-minute stepper test were significantly higher in patients compared to healthy controls (p < .05). BASMI values were significantly lower in the non-biological treatment group compared to the biological group (p < .05). Step counts showed weak correlation with BASMI (r = -0.142; p = .167), moderate-strong correlation with BASDAI (r = -0.458; p < .001), ASQoL (r = -0.450; p < .001), ASDAS-CRP (r = -0.361; p < .001), trunk extensor and flexor muscle endurance (r = 0.489; p < .001, r = 0.485; p < .001), right and left trunk lateral flexor muscle endurance (r = 0.584; p < .001, r = 0.572; p < .001), and BASFI (r = -0.582; p < .001). Step count variance was explained by BASMI, BASDAI, BASFI, ASQoL, and trunk endurance, accounting for 34.1% of the total variance. These findings may assist clinicians in planning personalized rehabilitation programs by considering not only functional limitations but also treatment history of the patients with axSpA. Understanding the effects of pharmacological treatment history on exercise capacity and core muscle endurance may guide the development of more effective physiotherapy approaches.Keywords
This publication has 48 references indexed in Scilit:
- Synchronous and asynchronous remote core stability exercises in patients with axial spondyloarthritis: a randomized-controlled clinical trialIrish Journal of Medical Science (1971 -), 2024
- Determinants of the Physician Global Assessment of Disease Activity and Influence of Contextual Factors in Early Axial SpondyloarthritisArthritis Care & Research, 2022
- Benefit of Biological Drugs for Quality of Life in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Clinical Trials2020
- Core stability and balance in patients with ankylosing spondylitisRheumatology International, 2019
- Decreased physical activity and cardiorespiratory fitness in adults with ankylosing spondylitis: a cross-sectional controlled studyRheumatology International, 2015
- Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaireRheumatology International, 2013
- Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS‐G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ‐S)Arthritis Care & Research, 2011
- The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validityClinical Rheumatology, 2004
- A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validityRheumatology International, 2004
- Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitisArthritis & Rheumatism, 2003